These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1351523)

  • 1. DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells.
    Falk SJ; Smith PJ
    Int J Radiat Biol; 1992 Jun; 61(6):749-57. PubMed ID: 1351523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.
    Hennequin C; Giocanti N; Balosso J; Favaudon V
    Cancer Res; 1994 Apr; 54(7):1720-8. PubMed ID: 8137287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced sensitivity to camptothecin in ataxia-telangiectasia cells and its relationship with the expression of DNA topoisomerase I.
    Smith PJ; Makinson TA; Watson JV
    Int J Radiat Biol; 1989 Feb; 55(2):217-31. PubMed ID: 2563396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
    Kim JS; Amorino GP; Pyo H; Cao Q; Choy H
    Radiother Oncol; 2002 Jan; 62(1):61-7. PubMed ID: 11830313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
    Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of olaparib and camptothecin for effective radiosensitization.
    Miura K; Sakata K; Someya M; Matsumoto Y; Matsumoto H; Takahashi A; Hareyama M
    Radiat Oncol; 2012 Apr; 7():62. PubMed ID: 22524618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines.
    Ng CE; Bussey AM; Raaphorst GP
    Int J Radiat Biol; 1994 Jul; 66(1):49-57. PubMed ID: 8027612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells.
    Boothman DA; Wang M; Schea RA; Burrows HL; Strickfaden S; Owens JK
    Int J Radiat Oncol Biol Phys; 1992; 24(5):939-48. PubMed ID: 1332930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin.
    Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z
    Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells.
    Jones CB; Clements MK; Wasi S; Daoud SS
    Cancer Chemother Pharmacol; 1997; 40(6):475-83. PubMed ID: 9332461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
    Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW
    Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyguanosine enhances the cytotoxicity of the topoisomerase I inhibitor camptothecin by reducing the repair of double-strand breaks induced in replicating DNA.
    Squires S; Ryan AJ; Strutt HL; Smith PJ; Johnson RT
    J Cell Sci; 1991 Dec; 100 ( Pt 4)():883-93. PubMed ID: 1726104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The topoisomerase I poison camptothecin generates a Chk1-dependent DNA damage checkpoint signal in fission yeast.
    Wan S; Capasso H; Walworth NC
    Yeast; 1999 Jul; 15(10A):821-8. PubMed ID: 10407262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy.
    Chen BM; Chen JY; Kao M; Lin JB; Yu MH; Roffler SR
    Gynecol Oncol; 2000 Nov; 79(2):272-80. PubMed ID: 11063656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase I activity and cellular response to radiation in Chinese hamster cells.
    Zanier R; De Salvia R; Fiore M; Degrassi F
    Int J Radiat Biol; 1996 Sep; 70(3):251-9. PubMed ID: 8800196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 status plays no role in radiosensitizing effects of SN-38, a camptothecin derivative.
    Xie X; Sasai K; Shibuya K; Tachiiri S; Nihei K; Ohnishi T; Hiraoka M
    Cancer Chemother Pharmacol; 2000; 45(5):362-8. PubMed ID: 10803918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
    Zhou Y; Gwadry FG; Reinhold WC; Miller LD; Smith LH; Scherf U; Liu ET; Kohn KW; Pommier Y; Weinstein JN
    Cancer Res; 2002 Mar; 62(6):1688-95. PubMed ID: 11912141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cell survival, DNA double strand breaks, and DNA synthesis during concurrent camptothecin and X-radiation treatments.
    Ng CE; Mazaheri K; Payant C; Raaphorst GP
    Int J Cancer; 2001 Oct; 96(5):277-85. PubMed ID: 11582580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the effect of camptothecin in x-irradiated L5178Y-R and L5178Y-S cells by benzamide.
    Gradzka I; Iwaneńko T; Kruszewski M; Szumiel I; Kapiszewska M; Lange CS; Afanasjev G
    Radiat Environ Biophys; 1996 Aug; 35(3):185-91. PubMed ID: 8880961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
    Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
    Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.